Alberto Joven Trinidad, APRN-CNS | |
8803 S 101st East Ave Ste 320, Tulsa, OK 74133-5732 | |
(918) 294-8000 | |
Not Available |
Full Name | Alberto Joven Trinidad |
---|---|
Gender | Male |
Speciality | Nurse Practitioner |
Experience | 12 Years |
Location | 8803 S 101st East Ave Ste 320, Tulsa, Oklahoma |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700137064 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
364SA2100X | Clinical Nurse Specialist - Acute Care | R0097461 (Oklahoma) | Secondary |
364SA2100X | Clinical Nurse Specialist - Acute Care | 97461 (Oklahoma) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Hillcrest Hospital South | Tulsa, OK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ahs Oklahoma Physician Group Llc | 9436122496 | 298 |
News Archive
The waiver approved by HHS means elderly people who need long-term care can be put in programs that will offer services in their homes and help them stay out of nursing homes, the Associated Press reports.
The FDA and representatives from the medical device industry have reached an agreement in principle on proposed recommendations for the third reauthorization of a medical device user fee program.
An Economist editorial examines the relief and recovery efforts in Haiti and the "vital" importance of planning for rebuilding the country "before the world's generosity turns to cynicism. Fortunately there is a blueprint, drawn up by Haiti's government and presented to donors last year. It calls for investment to be targeted on infrastructure, basic services and combating soil erosion to make farmers more productive and the country less vulnerable to hurricanes. The pressing question is who should do it and how."
PEPID, the top developer of clinical decision-support information and technology for healthcare professionals, has announced a partnership with the American Hospital Formulary Service, the premier provider of drug information. This partnership will put the AFHS Essentials drug information in electronic format, delivered on any mobile device or within any EMR system.
Cerus Corporation announced today that INTERCEPT-treated platelet components were found to be effective for patient support following extended six and seven day storage in a clinical study conducted at four sites in Europe. These data further confirm the safety and therapeutic efficacy of platelets treated with the INTERCEPT Blood System, a pathogen inactivation treatment designed to protect against transfusion-transmitted diseases.
› Verified 5 days ago
Entity Name | Ahs Oklahoma Physician Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235182775 PECOS PAC ID: 9436122496 Enrollment ID: O20040817001197 |
News Archive
The waiver approved by HHS means elderly people who need long-term care can be put in programs that will offer services in their homes and help them stay out of nursing homes, the Associated Press reports.
The FDA and representatives from the medical device industry have reached an agreement in principle on proposed recommendations for the third reauthorization of a medical device user fee program.
An Economist editorial examines the relief and recovery efforts in Haiti and the "vital" importance of planning for rebuilding the country "before the world's generosity turns to cynicism. Fortunately there is a blueprint, drawn up by Haiti's government and presented to donors last year. It calls for investment to be targeted on infrastructure, basic services and combating soil erosion to make farmers more productive and the country less vulnerable to hurricanes. The pressing question is who should do it and how."
PEPID, the top developer of clinical decision-support information and technology for healthcare professionals, has announced a partnership with the American Hospital Formulary Service, the premier provider of drug information. This partnership will put the AFHS Essentials drug information in electronic format, delivered on any mobile device or within any EMR system.
Cerus Corporation announced today that INTERCEPT-treated platelet components were found to be effective for patient support following extended six and seven day storage in a clinical study conducted at four sites in Europe. These data further confirm the safety and therapeutic efficacy of platelets treated with the INTERCEPT Blood System, a pathogen inactivation treatment designed to protect against transfusion-transmitted diseases.
› Verified 5 days ago
Entity Name | Ahs Oklahoma Heart Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780857540 PECOS PAC ID: 4587737135 Enrollment ID: O20080716000032 |
News Archive
The waiver approved by HHS means elderly people who need long-term care can be put in programs that will offer services in their homes and help them stay out of nursing homes, the Associated Press reports.
The FDA and representatives from the medical device industry have reached an agreement in principle on proposed recommendations for the third reauthorization of a medical device user fee program.
An Economist editorial examines the relief and recovery efforts in Haiti and the "vital" importance of planning for rebuilding the country "before the world's generosity turns to cynicism. Fortunately there is a blueprint, drawn up by Haiti's government and presented to donors last year. It calls for investment to be targeted on infrastructure, basic services and combating soil erosion to make farmers more productive and the country less vulnerable to hurricanes. The pressing question is who should do it and how."
PEPID, the top developer of clinical decision-support information and technology for healthcare professionals, has announced a partnership with the American Hospital Formulary Service, the premier provider of drug information. This partnership will put the AFHS Essentials drug information in electronic format, delivered on any mobile device or within any EMR system.
Cerus Corporation announced today that INTERCEPT-treated platelet components were found to be effective for patient support following extended six and seven day storage in a clinical study conducted at four sites in Europe. These data further confirm the safety and therapeutic efficacy of platelets treated with the INTERCEPT Blood System, a pathogen inactivation treatment designed to protect against transfusion-transmitted diseases.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Alberto Joven Trinidad, APRN-CNS 1265 S Utica Ave, Suite 105, Tulsa, OK 74104-4243 Ph: (918) 749-6400 | Alberto Joven Trinidad, APRN-CNS 8803 S 101st East Ave Ste 320, Tulsa, OK 74133-5732 Ph: (918) 294-8000 |
News Archive
The waiver approved by HHS means elderly people who need long-term care can be put in programs that will offer services in their homes and help them stay out of nursing homes, the Associated Press reports.
The FDA and representatives from the medical device industry have reached an agreement in principle on proposed recommendations for the third reauthorization of a medical device user fee program.
An Economist editorial examines the relief and recovery efforts in Haiti and the "vital" importance of planning for rebuilding the country "before the world's generosity turns to cynicism. Fortunately there is a blueprint, drawn up by Haiti's government and presented to donors last year. It calls for investment to be targeted on infrastructure, basic services and combating soil erosion to make farmers more productive and the country less vulnerable to hurricanes. The pressing question is who should do it and how."
PEPID, the top developer of clinical decision-support information and technology for healthcare professionals, has announced a partnership with the American Hospital Formulary Service, the premier provider of drug information. This partnership will put the AFHS Essentials drug information in electronic format, delivered on any mobile device or within any EMR system.
Cerus Corporation announced today that INTERCEPT-treated platelet components were found to be effective for patient support following extended six and seven day storage in a clinical study conducted at four sites in Europe. These data further confirm the safety and therapeutic efficacy of platelets treated with the INTERCEPT Blood System, a pathogen inactivation treatment designed to protect against transfusion-transmitted diseases.
› Verified 5 days ago
Teressa Headrick Lemaster, CNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1705 E 19th St, Suite 302, Tulsa, OK 74104 Phone: 918-748-7585 Fax: 918-748-7539 | |
Lisa Darcell Davis, APRN-CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 6161 S Yale Ave, Suite A100, Tulsa, OK 74136 Phone: 918-494-8500 Fax: 918-307-5578 | |
Suzanne Kirby, Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1145 S Utica Ave Ste 1105, Tulsa, OK 74104 Phone: 918-579-5749 | |
Kristin Mariah Pruitt, APRN-CNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1265 S Utica Ave, Suite 300, Tulsa, OK 74104 Phone: 918-592-0999 Fax: 918-592-1021 | |
Ruth Ann Fritz, CNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 6465 S Yale Ave Ste 401, Tulsa, OK 74136 Phone: 918-561-6141 Fax: 918-582-3593 | |
Tammy Irene Joplin, APRN Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1923 S Utica Ave, Tulsa, OK 74104 Phone: 918-744-2769 | |
Julia Anne Jackson, APRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1422 E 71st St Ste B, Tulsa, OK 74136 Phone: 918-710-0422 Fax: 918-949-6681 |